The features of skin inflammation induced by lupus serum
Copyright © 2016 Elsevier Inc. All rights reserved.
Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 165(2016) vom: 24. Apr., Seite 4-11 |
---|---|
Auteur principal: | |
Autres auteurs: | , , |
Format: | Article en ligne |
Langue: | English |
Publié: |
2016
|
Accès à la collection: | Clinical immunology (Orlando, Fla.) |
Sujets: | Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't IgG Lupus serum Skin inflammation Systemic lupus erythematosus Autoantibodies Cytokines Immune Sera |
Résumé: | Copyright © 2016 Elsevier Inc. All rights reserved. We recently developed a model of lupus serum-induced skin inflammation, which was used to study the pathogenesis of skin injury in systemic lupus erythematosus (SLE). We further characterized the features of lupus serum-induced skin inflammation. This skin inflammation was evident within 3h and lasted for at least two weeks. The skin inflammation was characterized by an influx of monocytic, CD11b+cells and by a scarcity of T and B lymphocytes. Depletion of IgG from the serum abrogated the skin inflammatory response. The skin inflammation was related to lupus patients' skin history but not to SLE disease activity and type of autoantibody. The expression of TNFR1, NF-kB and MCP-1 was increased locally in skin lesions. The TLR9 ligand and lupus serum act synergistically to trigger skin inflammation. These findings suggest that this novel model is valuable for the study of the pathogenesis and therapy of skin injury in SLE |
---|---|
Description: | Date Completed 31.08.2016 Date Revised 19.04.2016 published: Print-Electronic Citation Status MEDLINE |
ISSN: | 1521-7035 |
DOI: | 10.1016/j.clim.2016.02.007 |